BCAC News
Information for LGBTQI+ people with cancer
BCAC is aware that the breast cancer experience presents some unique challenges for LGBTQI+ people.
Precision Health Now and in the Future – BCAC’s submission
BCAC has responded to a call from Te Manatū Hauora (Ministry of Health) for input on the topic of Precision Health, which is being considered for inclusion in the next Long-term Insights Briefing to Government. BCAC’s Fay Sowerby has written a comprehensive submission, in which she describes how both precision health and precision medicine present huge opportunities for improvements in breast cancer care.
Patient-centred approaches needed to improve early breast cancer care in NZ
BCAC recently contributed to an analysis of the early breast cancer pathway in Aotearoa New Zealand.
Another busy successful year for BCAC
BCAC’s 16th AGM on Tuesday evening went very well.
BCAC enjoys local breast cancer conference
BCAC Committee members Fay Sowerby, Libby Burgess and Emma Crowley attended the Breast Cancer inSIGhts conference on 1-3 September 2022 in Auckland.
Māori women with advanced breast cancer tell their stories
Recently, BCAC and Sweet Louise filmed more stories from women living with advanced breast cancer.
Exciting trial results with trastuzumab deruxtecan (Enhertu)
Latest results from clinical trials with trastuzumab deruxtecan (brand name: Enhertu) have shown significant benefits for two groups of patients with advanced breast cancer: those with high levels
Pharmac’s latest breast cancer drug funding ‘way short’.
Pharmac recently announced $190 million of new funding for medicines. However, only one breast cancer drug made it onto their investment list.
Neoadjuvant patient decision aid
For many women recently diagnosed with breast cancer, the treatment process can be overwhelming and stressful.
